Reconcile AI attribution, instrument procurement drag, standardize biotech reporting, contain FinTech payment leakage, tighten nonprofit renewal forecasting, and narrow robotics revenue claims until the control packet is stronger.
RECONCILE
AI governance
Tier: PRESSURED
Owner: Chief AI Officer
Audience: Board technology committee
Narrative: AI demand is real, but attribution drift is still obscuring which control-led motions actually create revenue.
Breakage score: 73
Standardize one sourced-versus-influenced evidence packet for every AI governance win above the board-review threshold.
INSTRUMENT
Procurement / trust
Tier: PRESSURED
Owner: Chief Commercial Officer
Audience: Board growth committee
Narrative: Procurement demand is measurable, but the pipeline blind spot is still too wide between trust effort and booked revenue.
Breakage score: 69
Add one canonical delay-and-reuse tagging model so procurement effort can be measured directly against revenue timing.
STANDARDIZE
Biotech / diagnostics
Tier: CONSTRAINED
Owner: Quality systems lead
Audience: Board compliance committee
Narrative: Biotech is strategically strong, though reporting fragmentation keeps weakening the commercial story.
Breakage score: 75
Publish one commercialization rollup for the biotech cluster and make it the only board-facing reporting packet.
CONTAIN
FinTech
Tier: BROKEN
Owner: Chief Revenue Officer
Audience: Board finance committee
Narrative: FinTech is strong on demand, but payment leakage is still too high for clean board confidence.
Breakage score: 82
Create one canonical exception taxonomy that connects merchant risk, payment reconciliation, and treasury outcomes.